Adverum Biotechnologies Statistics Share Statistics Adverum Biotechnologies has 20.89M
shares outstanding. The number of shares has increased by 0.43%
in one year.
Shares Outstanding 20.89M Shares Change (YoY) 0.43% Shares Change (QoQ) 0.42% Owned by Institutions (%) 73.02% Shares Floating 13.83M Failed to Deliver (FTD) Shares 169 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 1.03M, so 4.95% of the outstanding
shares have been sold short.
Short Interest 1.03M Short % of Shares Out 4.95% Short % of Float 5.64% Short Ratio (days to cover) 7.47
Valuation Ratios The PE ratio is -0.71 and the forward
PE ratio is -0.73.
Adverum Biotechnologies's PEG ratio is
0.
PE Ratio -0.71 Forward PE -0.73 PS Ratio 92.38 Forward PS 3.1 PB Ratio 1.31 P/FCF Ratio -0.99 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Adverum Biotechnologies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.73,
with a Debt / Equity ratio of 1.3.
Current Ratio 5.73 Quick Ratio 5.73 Debt / Equity 1.3 Debt / EBITDA -0.72 Debt / FCF -0.99 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $6.45K Profits Per Employee $-844.69K Employee Count 155 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -65.64% in the
last 52 weeks. The beta is 0.77, so Adverum Biotechnologies's
price volatility has been higher than the market average.
Beta 0.77 52-Week Price Change -65.64% 50-Day Moving Average 2.5 200-Day Moving Average 4.2 Relative Strength Index (RSI) 40.02 Average Volume (20 Days) 257,493
Income Statement In the last 12 months, Adverum Biotechnologies had revenue of 1M
and earned -130.93M
in profits. Earnings per share was -6.62.
Revenue 1M Gross Profit -2.65M Operating Income -139.16M Net Income -130.93M EBITDA -127.27M EBIT -139.16M Earnings Per Share (EPS) -6.62
Full Income Statement Balance Sheet The company has 60.65M in cash and 91.7M in
debt, giving a net cash position of -31.05M.
Cash & Cash Equivalents 60.65M Total Debt 91.7M Net Cash -31.05M Retained Earnings -1.07B Total Assets 137.65M Working Capital 64.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -92.46M
and capital expenditures -388K, giving a free cash flow of -92.85M.
Operating Cash Flow -92.46M Capital Expenditures -388K Free Cash Flow -92.85M FCF Per Share -4.69
Full Cash Flow Statement Margins Gross margin is -265.3%, with operating and profit margins of -13915.9% and -13092.7%.
Gross Margin -265.3% Operating Margin -13915.9% Pretax Margin -13092.7% Profit Margin -13092.7% EBITDA Margin -12727.4% EBIT Margin -13915.9% FCF Margin -9285%
Dividends & Yields ADVM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ADVM is $30,
which is 1245.3% higher than the current price. The consensus rating is "Buy".
Price Target $30 Price Target Difference 1245.3% Analyst Consensus Buy Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 21, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Mar 21, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -12.6 Piotroski F-Score 3
